Business Wire India Entravision, a global ad-tech, media, and marketing solutions company, is proud to announce the unveiling of Adwake, the new brand name for its expanded mobile app promotion…
Business Wire India Quectel Wireless Solutions, a global IoT solutions provider, will be participating as an exhibitor and keynote speaker at the upcoming Connected Auto & Electric Vehicles (CAEV) India…
Business Wire India NIQ, the world’s leading authority in consumer intelligence, shares invaluable insights into thriving amidst polarizing consumer sentiments in Asia Pacific. The latest insights from NIQ’s Consumer Outlook…
Business Wire India Ant International, Official Partner of UEFA Euro 2024, with campaigns by Alipay+, Antom and WorldFirst, the company’s flagship digital payment services, seeks to engage fans around the…
Business Wire India Black & Veatch, a global leader in critical infrastructure solutions, will study the exploration and extraction of natural hydrogen and helium in Australia. The development study is…
Business Wire India VeriSilicon (688521.SH) today announced the integration of its Image Signal Processor (ISP) IP ISP8000, DeWarp Processor IP DW200, and 2.5D Graphics Processor Unit (GPU) IP GCNanoV into…
Business Wire India Esri, the global leader in location intelligence, is proud to announce that the US Department of State has selected the company’s chief scientist, Dr. Dawn Wright, among…
Business Wire India The Max Foundation (Max), a global nonprofit organization dedicated to accelerating health equity by delivering medication, technology, and supportive services to patients worldwide, BeiGene, a global oncology…
Business Wire India The launch offers hope to patients suffering from breast, ovarian, pancreatic and prostate cancers For better patient support, Zydus has also collaborated with MedGenome and launched Olaparib…
Business Wire India − Pre-Specified Interim Analysis Shows Positive Safety and Efficacy Results; Mezagitamab Safe and Well Tolerated −Takeda Intends to Initiate a Global Phase 3 Trial of Mezagitamab in…
dssenthil